{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:18:18Z","timestamp":1778141898175,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HD076901"],"award-info":[{"award-number":["R01HD076901"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CP Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijpharm.2018.04.040","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T06:48:14Z","timestamp":1524206894000},"page":"113-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation"],"prefix":"10.1016","volume":"545","author":[{"given":"Venkata K.","family":"Yellepeddi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raziye","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva P.","family":"Kambhampati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Sayre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rangaramanujam M.","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Ghandehari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.04.040_b0005","unstructured":"Abitec, 2016. Safety Data Sheet, Capmul MCM NF. Abitec, Inc."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0010","unstructured":"Abitec, 2018. Capmul brochure, in: Corporation, A. (Ed.). Abitec."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2013a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities","volume":"4","author":"Bavarsad Shahripour","year":"2014","journal-title":"Brain Behav."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.plefa.2012.08.008","article-title":"The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival","volume":"88","author":"Bazan","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0030","series-title":"Veterinary Pharmacology and Therapeutics","author":"Booth","year":"1982"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0035","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.nano.2014.03.008","article-title":"Fetal uptake of intra-amniotically delivered dendrimers in a mouse model of intrauterine inflammation and preterm birth","volume":"10","author":"Burd","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0040","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2217\/nnm.10.89","article-title":"Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration","volume":"5","author":"Dai","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1183\/09031936.04.00016804","article-title":"Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease","volume":"23","author":"Dekhuijzen","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0168-3659(02)00087-1","article-title":"Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers","volume":"81","author":"El-Sayed","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(03)00391-0","article-title":"Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers","volume":"265","author":"El-Sayed","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(24)36469-9","article-title":"Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium","volume":"280","author":"Ghandehari","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0075","doi-asserted-by":"crossref","first-page":"e0154437","DOI":"10.1371\/journal.pone.0154437","article-title":"Dendrimers target the ischemic lesion in rodent and primate models of nonarteritic anterior ischemic optic neuropathy","volume":"11","author":"Guo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2014.05.047","article-title":"In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin","volume":"472","author":"Hintzen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0085","doi-asserted-by":"crossref","first-page":"e61853","DOI":"10.1371\/journal.pone.0061853","article-title":"Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0090","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/bm5004465","article-title":"Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in using chambers","volume":"15","author":"Hubbard","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0095","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1167\/iovs.14-16250","article-title":"Systemic and intravitreal delivery of dendrimers to activated microglia\/macrophage in ischemia\/reperfusion mouse retina","volume":"56","author":"Kambhampati","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0100","doi-asserted-by":"crossref","first-page":"130ra146","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0105","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1021\/mp400371r","article-title":"Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation","volume":"10","author":"Lesniak","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0110","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1021\/acs.molpharmaceut.7b00198","article-title":"Validation of dissolution testing with biorelevant media: an OrBiTo study","volume":"14","author":"Mann","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0115","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/nn404872e","article-title":"Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest","volume":"8","author":"Mishra","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2006.11.047","article-title":"In vitro evaluation of dendrimer prodrugs for oral drug delivery","volume":"336","author":"Najlah","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12974-017-1004-5","article-title":"Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome","volume":"14","author":"Nance","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2015.07.009","article-title":"Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury","volume":"214","author":"Nance","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biomaterials.2016.05.044","article-title":"Nanoscale effects in dendrimer-mediated targeting of neuroinflammation","volume":"101","author":"Nance","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0140","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.nano.2017.06.014","article-title":"Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia","volume":"13","author":"Nemeth","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2007.08.033","article-title":"Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers","volume":"350","author":"Pisal","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-5173(00)00679-7","article-title":"Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells","volume":"215","author":"Tajarobi","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejpb.2013.01.019","article-title":"Charge affects the oral toxicity of poly(amidoamine) dendrimers","volume":"84","author":"Thiagarajan","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0160","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/mp300436c","article-title":"Evidence of oral translocation of anionic G6.5 dendrimers in mice","volume":"10","author":"Thiagarajan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2012.05.008","article-title":"Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model","volume":"82","author":"Wagner","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.04.040_b0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0168-3659(95)00057-F","article-title":"Site-specific drug delivery and penetration enhancement in the gastrointestinal tract","volume":"36","author":"Yeh","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.04.040_b0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/17425240903061251","article-title":"Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications","volume":"6","author":"Yellepeddi","year":"2009","journal-title":"Expert Opin. Drug Deliv."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318302576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318302576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:33:28Z","timestamp":1759916008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318302576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0378517318302576"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.04.040","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}